CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line chemotherapy for patients with mCRPC

BGICC 2019

Neoadjuvant hormonal treatment for luminal breast cancer: Rationale, evidence and outcome

Fertility issues during adjuvant treatment in premenopausal breast cancer patients

Endocrine manipulations in premenoupausal metastatic HER2 positive breast cancer: breaking the silence

SABCS 2018: Highlights in breast cancer treatment

Prognostic value of circulating tumour-cell count in metastatic breast cancer patients

Circulating tumour-cell count used to decide between treatments for breast cancer patients

Osteoporosis and osteopenia in elderly patients

Updates from the EMBRACA trial for advanced breast cancer

Advances in metastatic non small cell lung cancer

Editor's Choice for August 2018